CAS: 1007223-17-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Olokizumab REF: TM-T76753CAS: 1007223-17-7 | 95% - 95% | 237.00 €~1,658.00 € | Tue 21 Jan 25 |
 | Olokizumab REF: 3D-CLA1257CAS: 1007223-17-7 | - - - | To inquire | Fri 31 Jan 25 |
Olokizumab
CAS:1007223-17-7
Revdofilimab (ABBV-368) is a human IgG monoclonal antibody targeting OX 40 with potential anticancer activity.
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T76753
| 1mg | 237.00 € | ||
| 5mg | 612.00 € | ||
| 10mg | 833.00 € | ||
| 25mg | 1,209.00 € | ||
| 50mg | 1,658.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 3D-CLA1257
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 31 Jan 2025
